What is Life Biosciences worth?
$500.0Mlast known valuation
Life Biosciences last raised $31.0M in its Early Stage VC (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Life Biosciences
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC | $31.0M | ▮ | ▮ |
| May 2020 | Later Stage VC | $74.8M | ▮ | ▮ |
| Aug 2018 | Early Stage VC | $48.6M | ▮ | ▮ |
How Life Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Life Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Life Biosciences worth?
- Life Biosciences's last known valuation is $500.0M.
- How much has Life Biosciences raised?
- Life Biosciences has raised $255.2M in total funding across 3 recorded rounds.
- When did Life Biosciences last raise?
- Life Biosciences last raised in Nov 2025 (Early Stage VC), raising $31.0M.